Clinical Trial Update: Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study of clobazam as adjunctive therapy in children with Dravet syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• ONFI (clobazam)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Dravet Syndrome | Phase 3 | Status: WITHDRAWN